Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127982071 | 12798207 | 1 | I | 20160923 | 20160930 | 20160930 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-080336 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160930 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127982071 | 12798207 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 20 MG, QD | 21436 | 20 | MG | QD | |||||||
| 127982071 | 12798207 | 2 | SS | ABILIFY MAINTENA | ARIPIPRAZOLE | 1 | Intramuscular | UNK, QMO | 0 | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127982071 | 12798207 | 1 | Product used for unknown indication |
| 127982071 | 12798207 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127982071 | 12798207 | Dyskinesia | |
| 127982071 | 12798207 | Intentional product misuse | |
| 127982071 | 12798207 | Off label use | |
| 127982071 | 12798207 | Tongue biting | |
| 127982071 | 12798207 | Trismus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127982071 | 12798207 | 1 | 201609 | 201609 | 0 | |
| 127982071 | 12798207 | 2 | 201609 | 0 |